How pharmaceutical brand teams can design new pathways to market and compete on better health outcomes

John G. Singer

This article looks at why the pandemic should prompt the pharmaceutical industry to look at strategies beyond drug promotion and look, instead, at partnerships that ultimately provide better health outcomes.

How the pandemic is changing the US healthcare system

The $20 trillion consumer-driven economy in the United States is breaking structurally, in the grips of the Big Fear and unseen forces of compression. Americans are hoarding cash, slashing spending...

Learn more Get a demo